Saturday, October 20, 2018

WHO on MSF patent challenge: a win in India could save lives

MSF’s unprecedented legal challenge of the patent on Pfizer’s pneumonia vaccine Prevenar 13 in India is a “rational … coherent” strategy which, if successful, could save lives by opening the way for cheaper vaccines, a WHO vaccine expert tells Development Today.


Martin Friede, Initiative for Vaccine Research, WHO
Photo: WHO

Development Today is a subscription-based online journal. To subscribe click here.

If you are already a subscriber to Development Today please log in.

Would you like to know more about Development Today? Click here.